Funder: Novo Nordisk Foundation
Due Dates: January 12, 2027, at 14:00 CET (Application deadline) | May 2027 (Results) | August 1, 2027–June 1, 2028 (Project start window)
Funding Amounts: Up to DKK 12.5 million over 5 years; up to DKK 25 million over 7 years with relocation support
Summary: Supports independent mid-career research leaders pursuing novel fundamental research into the human organism and mechanisms of health and disease.
Key Information: Applicants must work and maintain their primary research group in Denmark during the project; professors and researchers with clinical obligations cannot apply.
Description
The Novo Nordisk Foundation’s Hallas-Møller Ascending Investigator grant supports independent research leaders with the ambition and potential to reach the highest international level in their fields. Part of the Research Leader Programme, it promotes and consolidates accomplished associate professors in Denmark through novel, ambitious projects with high scientific impact. International recruitment is a priority, with additional support available to relocate research groups to Denmark.
The programme funds fundamental bioscience and basic biomedicine relevant to understanding the human organism and mechanisms underlying health and disease. Fields include molecular and cell biology, bioinformatics, biological modelling, enzymology, genetics, microbiology, pharmacology, experimental physiology, biophysics, biochemistry, biology and biostatistics. Research typically uses animal, cellular or subcellular models, or in silico approaches.
